Advent strikes €4.1bn deal to sell generic drugmaker Zentiva to GTCR

All NewsSeptember 11, 2025

Sale is second private equity-backed healthcare transaction within weeks in Europe

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent